EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte Studie

A randomized, double‐blind, placebo‐controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adults

Sung-Kwon Lee iD, Dong-Ryung Lee iD, Hae-Lim Kim iD, Bong-Keun Choi iD, Kang-Beom Kwon

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8224 ↗

At a glance

Randomisierte kontrollierte Studie in Phytotherapy Research, 2024. Written by Sung-Kwon Lee and 4 co-authors. Institution: Research Institute, NUON Co., Ltd., Seongnam, Republic of Korea. Major MEDLINE topics: Echinacea, Plant Extracts, Killer Cells, Natural, Cytokines. Cited 4 times so far (Crossref); 53 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Echinacea purpurea (L.) Moench (EP), a medicinal plant native to North America, is now cultivated in various regions including Europe. With increasing popularity of Echinacea in Korea recently, a human clinical trial was conducted to evaluate immune‐enhancing efficacy and safety of EP 60% ethanolic extract (EPE) in Koreans. Eighty volunteers were recruited for this randomized, double‐blind, placebo‐controlled clinical trial. They were randomly divided into two groups and given either a daily dose of 200 mg of EPE or a placebo. All participants underwent testing for Natural Killer (NK) cell cytotoxic activity, serum cytokine levels (IL‐2, IL‐6, IL‐10, IL‐12, IFN‐γ, TNF‐α), Wisconsin Upper Respiratory Symptom Survey‐21 (WURSS‐21), and Multidimensional Fatigue Scale (MFS) during this study to assess changes in outcomes. After 8 weeks of EPE consumption, a significant increase in NK cell cytotoxic activity compared to the placebo was observed. Additionally, serum cytokine levels of IL‐2, IFN‐γ, and TNF‐α also significantly increased following EPE consumption. However, no significant changes were observed in WURSS‐21 and MFS before and after EPE consumption. Throughout the 8‐week study period, no adverse reactions were reported in relation to EPE consumption, and there were no clinically significant changes in diagnostic laboratory tests or vital signs in the EPE group. These results indicate that consumption of EPE could lead to immune improvement without any adverse effects. This clinical trial was the first to demonstrate beneficial effects of EPE consumption on immunity in Korean adults.

Subjects

MeSH terms (MEDLINE)

EchinaceaPlant ExtractsKiller Cells, NaturalCytokinesHumansDouble-Blind MethodMaleAdultFemaleMiddle AgedRepublic of KoreaEthanolYoung Adult

Author keywords

Echinacea purpureaKorean adultsclinical trialhealth functional foodimmune‐enhancing effectmedicinal plant

Substances

Plant ExtractsCytokinesEthanol

Authors and institutions

  • Research Institute, NUON Co., Ltd., Seongnam, Republic of Korea.
  • Department of Physiology, College of Korean Medicine, Wonkwang University, Iksan, Jeonbuk, Republic of Korea & Ilwonbio Co., Ltd, Iksan, Jeonbuk, Republic of Korea.

ORCID profiles: Sung-Kwon Lee, Dong-Ryung Lee, Hae-Lim Kim, Bong-Keun Choi

Cite

APA

Lee, S. K., Lee, D. R., Kim, H. L., Choi, B. K., & Kwon, K. B. (2024). A randomized, double‐blind, placebo‐controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adults. Phytotherapy Research. https://doi.org/10.1002/ptr.8224

Vancouver

Lee SK, Lee DR, Kim HL, Choi BK, Kwon KB. A randomized, double‐blind, placebo‐controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adults. Phytotherapy Research. 2024. doi:10.1002/ptr.8224

BibTeX
@article{Lee2024,
  author = {Lee, Sung-Kwon and Lee, Dong-Ryung and Kim, Hae-Lim and Choi, Bong-Keun and Kwon, Kang-Beom},
  title = {A randomized, double‐blind, placebo‐controlled study on immune improvement effects of ethanolic extract of Echinacea purpurea (L.) Moench in Korean adults},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8224}
}
Start for free →